MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., (“DraxImage”) www.draximage.com, a wholly Owned Subsidiary of Jubilant Pharma Ltd, announced today that the U.S. Food and Drug Administration has ...
YARDLEY, PA / ACCESSWIRE / May 5, 2021 / Jubilant Radiopharma, a business division of Jubilant Pharma Limited, and Cyclomedica Europe Ltd, a wholly owned subsidiary of Cyclopharm Limited (ASX:CYC), ...
Montreal, QC, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a Jubilant Pharma whollyowned subsidiary, is pleased to announce it has received approval from Health Canada for ...
MONTREAL - Jubilant DraxImage Inc., a wholly owned subsidiary of Jubilant Pharma Limited, is pleased to announce the receipt of the CE Mark certificate for its state-of-the-art RUBY Rubidium Elution ...
New Delhi, Oct 3: Jubilant Life Sciences today said its wholly-owned subsidiary has received approval from the US health regulator for RUBY-FILL-- Rubidium 82 generator and elution system -- used in ...
YARDLEY, Pa., Dec. 11, 2019 (GLOBE NEWSWIRE) -- On December 2, 2019, Jubilant DraxImage Inc. and certain of its affiliates (“Jubilant”) received notice of the favorable decision of the U.S.
Jubilant Life Sciences today said its wholly-owned subsidiary has received approval from the US health regulator for RUBY-FILL -- Rubidium 82 generator and elution system -- used in diagnosis of ...
Jubilant Radiopharma, a business division of Jubilant Pharma Limited, and Cyclomedica Europe Ltd, a wholly owned subsidiary of Cyclopharm Limited, will announce their partnership at the International ...
Jubilant Life Sciences today said its wholly-owned subsidiary has received approval from the US health regulator for RUBY-FILL -- Rubidium 82 generator and elution system -- used in diagnosis of ...
YARDLEY, PA / ACCESSWIRE / May 5, 2021 / Jubilant Radiopharma, a business division of Jubilant Pharma Limited, and Cyclomedica Europe Ltd, a wholly owned subsidiary of Cyclopharm Limited (ASX:CYC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results